by TractManager | Mar 9, 2017 | Emerging Technology Report
The Cobra PzF stent is a first-in-class nanocoated coronary stent that is FDA-approved for improving coronary luminal diameter in patients, including those with diabetes mellitus, with symptomatic ischemic heart disease due to de novo lesions in native coronary...
by TractManager | Mar 9, 2017 | Emerging Technology Report
Noctiva is a low-dose desmopressin nasal spray proposed to treat adults with nocturia due to nocturnal polyuria. Noctiva is a new formulation of an old drug which was first approved by the FDA in 1978 under the brand name DDAVP (Ferring Pharmaceuticals Inc.)....
by TractManager | Mar 9, 2017 | Clinical Utility Evaluation
This report evaluates the clinical utility of genetic testing for fragile X-associated primary ovarian insufficiency (FXPOI). The goal of this report is to assess how genetic testing of women with primary ovarian insufficiency (POI) to diagnose FXPOI changes...
by TractManager | Mar 9, 2017 | Health Technology Assessment
Purpose of Technology: Percutaneous kyphoplasty (KP) is an interventional procedure used to treat painful vertebral compression fractures related to osteoporosis. The procedure involves guided insertion of an inflatable bone tamp into the partially collapsed vertebral...
by TractManager | Mar 2, 2017 | Molecular Test Assessment
Prescription drug use in the United States has steadily increased. Following this trend, pharmacotherapy for the treatment of neuropsychiatric disorders has also increased over the past several decades. According to a 2012 national survey, antidepressants were...
Recent Comments